Pure Biologics S.A. (WSE: PUR)

Pure Biologics Revenue

Pure Biologics had revenue of 250.00K PLN in the quarter ending September 30, 2024, a decrease of -95.12%. This brings the company's revenue in the last twelve months to -10.52M, down -196.42% year-over-year. In the year 2023, Pure Biologics had annual revenue of 95.00K, down -85.65%.

• Revenue (ttm): -10.52M
• Revenue Growth: -196.42%
• P/S Ratio: n/a
• Revenue / Employee: -2.63M
• Employees: 51
• Market Cap: 60.65M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	95.00K	-567.00K	-85.65%
Dec 31, 2022	662.00K	408.00K	160.63%
Dec 31, 2021	254.00K	-318.00K	-55.59%
Dec 31, 2020	572.00K	-1.20M	-67.79%
Dec 31, 2019	1.78M	500.49K	39.24%